Pharmacy Learning Network

Your Go-To Resource for Clinical and Regulatory Updates for Pharmacy Professionals
@PopHealthNet

[Pharmacy Learning Network @PharmaLearnNet]

Dr Jennings shares findings from a new study evaluating RAAS inhibitors for the treatment of advanced chronic kidney disease. https://t.co/J90TcqL1R0

[Pharmacy Learning Network @PharmaLearnNet]

A Class II #recall has been issued for a #prescription #Medication used to reverse the effects of nondepolarizing neuromuscular blocking agents after surgery. https://t.co/vnHNwRkDyM

[Pharmacy Learning Network @PharmaLearnNet]

A prescription #drug used to manage hypertension is being recalled due to potential cross contamination. https://t.co/uquRTvKRVH

[Pharmacy Learning Network @PharmaLearnNet]

Several lots of hand sanitizer are being recalled after the US Food and Drug Administration found undeclared methanol in one. https://t.co/5No7aRSMlH

[Pharmacy Learning Network @PharmaLearnNet]

Nicole L Stout, DPT, CLT-LANA, FAPTA, shares her team’s research on distress screening and a quality improvement project to boost provider efficiency and close gaps in patients’ cancer #care
https://t.co/LrAK36bOUs

[Pharmacy Learning Network @PharmaLearnNet]

Our readership reported staffing and scheduling issues as the leading cause of burnout among pharmacists. What actions, if any, has your organization taken to address burnout? https://t.co/xT1YDZS6VW

[Pharmacy Learning Network @PharmaLearnNet]

Check out our #quiz and test your knowledge on the recommended dosage of an H2 blocker for gastroesophageal reflux disease. https://t.co/4iy2YgnsO2

[Pharmacy Learning Network @PharmaLearnNet]

Dr Jennings shares new guidance from the US Food and Drug Administration and National Institutes of Health regarding the efficacy of 2 monoclonal antibodies against the #Omicron subvariants BQ.1 and BQ.1.1. https://t.co/vFSjdfxP7J

[Pharmacy Learning Network @PharmaLearnNet]

In the second part of his coverage of AHA Scientific Sessions 2022, Dr Jennings shares 2 randomized trials designed to compare diuretics for the treatment of hypertension and #HeartFailure
https://t.co/CrDllHzWTD

[Pharmacy Learning Network @PharmaLearnNet]

In the latest issue of Talking Therapeutics, Dr Jennings highlights #data from American Heart Association Scientific Sessions 2022, including research into direct oral anticoagulants, a novel fibrate, and more. https://t.co/Yr8PM6dzkx

[Pharmacy Learning Network @PharmaLearnNet]

Dr Jennings discusses the potential of xenotransplantation, the transplant of nonhuman tissues and organs into a human recipient, for alleviating organ scarcity across the world. https://t.co/dapWHC3HK5

[Pharmacy Learning Network @PharmaLearnNet]

A Class I #Recall has been issued for atenolol tablets due to a bottle mistakenly containing clopidogrel. https://t.co/7i9JK6FPIS

[Pharmacy Learning Network @PharmaLearnNet]

Eric Tichy, PharmD, MBA, vice chair of pharmacy formulary, Mayo Clinic, offers insight into drug spending #trends that emerged over the course of 2021 and predicts how spending will continue to change. https://t.co/JCBEMWD1Ef

[Pharmacy Learning Network @PharmaLearnNet]

In the latest installment of Talking Therapeutics, Dr Jennings shares a randomized study in which patients with mild to moderate cases of #COVID19 were treated with either ivermectin or placebo. https://t.co/fWlkdyB52M

[Pharmacy Learning Network @PharmaLearnNet]

Social determinants of health, such as location and household income, influenced American Indian and Alaska Native individuals' use of clinical #pharmacy services. https://t.co/y2idPD0UOz

[Pharmacy Learning Network @PharmaLearnNet]

Want to stay up-to-date on all the featured content from our trusted brands? Follow their respective pages, designed to curate the latest clinical insights, industry news, conference coverage, and more with thought leaders in #PopulationHealth and more! https://t.co/O9hKg4gn3E

[Pharmacy Learning Network @PharmaLearnNet]

Tracing reports by pharmacists resulted in cost savings by reducing leftover medications and prompting #Pharmaceutical interventions for #patientsafety. https://t.co/1B3X2GnwtV

[Pharmacy Learning Network @PharmaLearnNet]

Dr Jennings shares a new study which suggests lower doses of guideline-directed medical therapy might still produce a significant benefit for patients. https://t.co/awGUPnLKoV

[Pharmacy Learning Network @PharmaLearnNet]

A Class II #recall has been issued for 103,150 vials of a #prescription bronchodilator following the report of a hair found in a vial. https://t.co/lG3oQUjHCS

[Pharmacy Learning Network @PharmaLearnNet]

In a session at #AMCPNexus 2022, speakers discussed the rise in #stimulant #overdoses with an emphasis on treatment options and how providers and health plans can better manage patients with stimulant use disorder. https://t.co/g3s5QbnhZ0